Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Predicting decline of kidney function in lupus nephritis using urine biomarkers.

Abulaban KM, Song H, Zhang X, Kimmel PL, Kusek JW, Nelson RG, Feldman HI, Vasan RS, Ying J, Mauer M, Nelsestuen GL, Bennett M, Brunner HI, Rovin BH.

Lupus. 2016 Aug;25(9):1012-8. doi: 10.1177/0961203316631629. Epub 2016 Feb 11.

2.

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

Skinner NE, Wroblewski MS, Kirihara JA, Nelsestuen GL, Seaquist ER.

Diabetes Ther. 2015 Sep;6(3):395-401. doi: 10.1007/s13300-015-0123-1. Epub 2015 Jul 22.

3.

Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium.

Hsu CY, Ballard S, Batlle D, Bonventre JV, Böttinger EP, Feldman HI, Klein JB, Coresh J, Eckfeldt JH, Inker LA, Kimmel PL, Kusek JW, Liu KD, Mauer M, Mifflin TE, Molitch ME, Nelsestuen GL, Rebholz CM, Rovin BH, Sabbisetti VS, Van Eyk JE, Vasan RS, Waikar SS, Whitehead KM, Nelson RG; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2015 May 7;10(5):894-902. doi: 10.2215/CJN.11541114. Epub 2015 Mar 4. Review.

4.

Elevated peptides in lung lavage fluid associated with bronchiolitis obliterans syndrome.

Stone MD, Harvey SB, Nelsestuen GL, Reilly C, Hertz MI, Wendt CH.

PLoS One. 2014 Jan 2;9(1):e84471. doi: 10.1371/journal.pone.0084471. eCollection 2014.

5.

Glycoproteins and glycosylation: apolipoprotein c3 glycoforms by top-down maldi-tof mass spectrometry.

Zhang Y, Sinaiko AR, Nelsestuen GL.

Methods Mol Biol. 2012;909:141-50. doi: 10.1007/978-1-61779-959-4_10.

PMID:
22903714
6.

Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides.

Mahoney DW, Therneau TM, Heppelmann CJ, Higgins L, Benson LM, Zenka RM, Jagtap P, Nelsestuen GL, Bergen HR, Oberg AL.

J Proteome Res. 2011 Sep 2;10(9):4325-33. doi: 10.1021/pr2001308. Epub 2011 Aug 2.

7.

Urinary Peptide patterns in native kidneys and kidney allografts.

Zhang Y, Oetting WS, Harvey SB, Stone MD, Monkkonen T, Matas AJ, Cosio FG, Nelsestuen GL.

Transplantation. 2009 Jun 27;87(12):1807-13. doi: 10.1097/TP.0b013e3181a66595.

8.

O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease.

Harvey SB, Zhang Y, Wilson-Grady J, Monkkonen T, Nelsestuen GL, Kasthuri RS, Verneris MR, Lund TC, Ely EW, Bernard GR, Zeisler H, Homoncik M, Jilma B, Swan T, Kellogg TA.

J Proteome Res. 2009 Feb;8(2):603-12. doi: 10.1021/pr800751x.

PMID:
19055479
9.

Temporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition?

Akkina SK, Zhang Y, Nelsestuen GL, Oetting WS, Ibrahlm HN.

J Proteome Res. 2009 Jan;8(1):94-103. doi: 10.1021/pr800646j.

10.

Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers.

Nelsestuen GL, Harvey SB, Zhang Y, Kasthuri RS, Sinaiko AR, Ely EW, Bernard GR, Homoncik M, Jilma B.

Proteomics Clin Appl. 2008 Feb;2(2):158-66. doi: 10.1002/prca.200780107. Epub 2008 Jan 15.

PMID:
21136822
11.

WITHDRAWN: Extraordinary apolipoprotein oxidation in chronic hepatitis C and liver cirrhosis.

Kasthuri RS, Harvey SB, Stone MD, Homoncik M, Jilma B, Nelsestuen GL.

Mol Cell Proteomics. 2007 Sep 5. [Epub ahead of print]

12.

Potential biomarkers of an exaggerated response to endotoxemia.

Kasthuri RS, Wroblewski M, Jilma B, Key NS, Nelsestuen GL.

Biomarkers. 2007 May-Jun;12(3):287-302.

PMID:
17453742
13.

Correlation of a T45S variant of apolipoprotein C1 with elevated BMI in persons of American Indian and Mexican ancestries.

Kasthuri RS, McMillan KR, Flood-Urdangarin C, Harvey SB, Wilson-Grady JT, Nelsestuen GL.

Int J Obes (Lond). 2007 Aug;31(8):1334-6. Epub 2007 Feb 20.

PMID:
17310220
14.

A functional polymorphism of apolipoprotein C1 detected by mass spectrometry.

Wroblewski MS, Wilson-Grady JT, Martinez MB, Kasthuri RS, McMillan KR, Flood-Urdangarin C, Nelsestuen GL.

FEBS J. 2006 Oct;273(20):4707-15. Epub 2006 Sep 18.

15.

Studying multiple protein profiles over time to assess biomarker validity.

Kasthuri RS, Verneris MR, Ibrahim HN, Jilma B, Nelsestuen GL.

Expert Rev Proteomics. 2006 Aug;3(4):455-64. Review.

PMID:
16901203
16.

Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid.

Zhang Y, Wroblewski M, Hertz MI, Wendt CH, Cervenka TM, Nelsestuen GL.

Proteomics. 2006 Feb;6(3):1001-10.

PMID:
16400684
17.

Plasma protein profiling: unique and stable features of individuals.

Nelsestuen GL, Zhang Y, Martinez MB, Key NS, Jilma B, Verneris M, Sinaiko A, Kasthuri RS.

Proteomics. 2005 Oct;5(15):4012-24.

PMID:
16130168
18.
19.

Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection.

Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH.

Proteomics. 2005 Apr;5(6):1705-13.

PMID:
15800973
20.

Efficacy of soluble phospholipids in the prothrombinase reaction.

Stone MD, Nelsestuen GL.

Biochemistry. 2005 Mar 15;44(10):4037-41.

PMID:
15751980
21.

Views on methods for monitoring recombinant factor VIIa in inhibitor patients.

Key NS, Nelsestuen GL.

Semin Hematol. 2004 Jan;41(1 Suppl 1):51-4. Review.

PMID:
14872422
22.

Mutagenesis of the gamma-carboxyglutamic acid domain of human factor VII to generate maximum enhancement of the membrane contact site.

Harvey SB, Stone MD, Martinez MB, Nelsestuen GL.

J Biol Chem. 2003 Mar 7;278(10):8363-9. Epub 2002 Dec 27.

23.
24.
25.

Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy.

Key NS, Christie B, Henderson N, Nelsestuen GL.

Thromb Haemost. 2002 Jul;88(1):60-5.

PMID:
12152680
26.
27.

Elevated function of blood clotting factor VIIa mutants that have enhanced affinity for membranes. Behavior in a diffusion-limited reaction.

Nelsestuen GL, Stone M, Martinez MB, Harvey SB, Foster D, Kisiel W.

J Biol Chem. 2001 Oct 26;276(43):39825-31. Epub 2001 Aug 21.

28.

Significance of reduced dimensionality in reaction kinetics: impact of multi-site particles.

Nelsestuen GL.

Chem Phys Lipids. 1999 Aug;101(1):37-44. Review.

PMID:
10810923
29.

Vitamin K-dependent proteins.

Nelsestuen GL, Shah AM, Harvey SB.

Vitam Horm. 2000;58:355-89. Review.

PMID:
10668405
31.

Steady-state enzyme kinetics in the Escherichia coli periplasm: a model of a whole cell biocatalyst.

Martinez MB, Flickinger MC, Nelsestuen GL.

J Biotechnol. 1999 May 28;71(1-3):59-66.

PMID:
10483101
32.

Membrane association with multiple calcium ions: vitamin-K-dependent proteins, annexins and pentraxins.

Nelsestuen GL, Ostrowski BG.

Curr Opin Struct Biol. 1999 Aug;9(4):433-7. Review.

PMID:
10449363
33.

Enhancement of human protein C function by site-directed mutagenesis of the gamma-carboxyglutamic acid domain.

Shen L, Shah AM, Dahlbäck B, Nelsestuen GL.

J Biol Chem. 1998 Nov 20;273(47):31086-91.

34.

Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

Shah AM, Kisiel W, Foster DC, Nelsestuen GL.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4229-34.

35.

Ionic properties of membrane association by vitamin K-dependent proteins: the case for univalency.

McDonald JF, Evans TC Jr, Emeagwali DB, Hariharan M, Allewell NM, Pusey ML, Shah AM, Nelsestuen GL.

Biochemistry. 1997 Dec 16;36(50):15589-98.

PMID:
9398287
36.

Enhancing the activity of protein C by mutagenesis to improve the membrane-binding site: studies related to proline-10.

Shen L, Shah AM, Dahlbäck B, Nelsestuen GL.

Biochemistry. 1997 Dec 23;36(51):16025-31.

PMID:
9440875
37.
38.
39.

Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site.

McDonald JF, Shah AM, Schwalbe RA, Kisiel W, Dahlbäck B, Nelsestuen GL.

Biochemistry. 1997 Apr 29;36(17):5120-7.

PMID:
9136872
40.

Importance of cis-proline 22 in the membrane-binding conformation of bovine prothrombin.

Evans TC Jr, Nelsestuen GL.

Biochemistry. 1996 Jun 25;35(25):8210-5.

PMID:
8679575
41.
43.
44.

Kinetics of annexin VI, calcium, and phospholipid association and dissociation.

Lu Y, Bazzi MD, Nelsestuen GL.

Biochemistry. 1995 Aug 29;34(34):10777-85.

PMID:
7662658
46.

Association of rat C-reactive protein and other pentraxins with rat lipoproteins containing apolipoproteins E and A1.

Schwalbe RA, Coe JE, Nelsestuen GL.

Biochemistry. 1995 Aug 22;34(33):10432-9.

PMID:
7544614
47.

Reaction of nitric oxide and its derivatives with sulfites: a possible role in sulfite toxicity.

Harvey SB, Nelsestuen GL.

Biochim Biophys Acta. 1995 May 29;1267(1):41-4.

48.
49.

Calcium and membrane-binding properties of monomeric and multimeric annexin II.

Evans TC Jr, Nelsestuen GL.

Biochemistry. 1994 Nov 15;33(45):13231-8.

PMID:
7947730
50.

Supplemental Content

Loading ...
Support Center